On the occasion of World AIDS Day 2021, the U.S. Mission Nigeria recognizes and honors those we have lost to HIV/AIDS and the resiliency of those who fight for epidemic control in Nigeria.
The United States is committed to leading the global response to the COVID-19 pandemic, becoming an arsenal of vaccines for the world, and helping every country build back better. At the same time, we continue to lead global efforts to end the HIV epidemic.
The U.S. government’s theme for World AIDS Day 2021 is “Ending the HIV Epidemic: Equitable Access, Everyone’s Voice.” This theme reflects the U.S. government’s strong bipartisan commitment to ending the HIV epidemic globally and in the United States. It further highlights the ongoing efforts of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to assist countries in achieving sustained epidemic control of HIV by supporting?equitable?health services?and solutions, enduring?national?health systems?and capabilities, and?lasting collaborations. It also conveys PEPFAR’s deep commitment to ensure that the diverse voices of all affected ages, genders, and population groups are heard and valued in the global AIDS response.
While still facing unprecedented challenges including, challenges associated with the COVID-19 pandemic, PEPFAR-supported programs have safely ensured access to HIV services, including core prevention services that were affected by early COVID-19 mitigation measures. Many of these HIV prevention programs have since expanded significantly, while keeping clients and staff safe from COVID-19.
Through PEPFAR, the U.S. government has saved more than 20 million lives, prevented millions of HIV infections, and supported many countries to reach epidemic control of HIV. Globally, PEPFAR has helped replace death and despair with vibrant life and hope, and tragedy with triumph. According to UNAIDS, AIDS-related deaths have been cut by 64 percent since their peak in 2004, and new HIV infections have been reduced by 52 percent since their peak in 1997.
Since 2003, the U.S. government, through PEPFAR, has invested more than $85 billion in the global HIV/AIDS response and saved more than 17 million lives, working in 54 countries.
IIn Nigeria, PEPFAR has invested more than $6 billion in the national HIV/AIDS response.
Some measures of our success include, more than 1.6 million, women, and children currently on HIV treatment. In Financial Year 2021 alone:
- More than 10 million people have received HIV counselling and testing services;
- Approximately 1.5 million pregnant women received HIV testing and counselling toward prevention of mother-to-child transmission of HIV;
- More than 1.6 million people living with HIV received support to improve quality of life, including TB/HIV care services and;
- About 850 thousand orphans and vulnerable children received care and support services
PEPFAR-supported public health, clinical, and laboratory platforms have helped Nigeria to keep Ebola virus disease, H1N1, and other deadly diseases from raging out of control – and are significantly aiding the Nigeria COVID19 response, while advancing the Nigeria HIV/AIDS response.
Distributed by APO Group on behalf of U.S. Embassy and Consulate in Nigeria.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
